These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28268049)

  • 1. Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors.
    De Simone A; Fiori J; Naldi M; D'Urzo A; Tumiatti V; Milelli A; Andrisano V
    J Pharm Biomed Anal; 2017 Sep; 144():159-166. PubMed ID: 28268049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct determination of GSK-3β activity and inhibition by UHPLC-UV-vis diode arrays detector (DAD).
    D'Urzo A; De Simone A; Fiori J; Naldi M; Milelli A; Andrisano V
    J Pharm Biomed Anal; 2016 May; 124():104-111. PubMed ID: 26942334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ESI-MS/MS method for screening of small-molecule mixtures against glycogen synthase kinase-3beta (GSK-3beta).
    Partserniak I; Werstuck G; Capretta A; Brennan JD
    Chembiochem; 2008 May; 9(7):1065-73. PubMed ID: 18348127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.
    Liang Z; Li QX
    ACS Chem Neurosci; 2018 May; 9(5):1166-1183. PubMed ID: 29381861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Gao Y; Zhang P; Cui A; Ye DY; Xiang M; Chu Y
    Bioorg Med Chem; 2018 Nov; 26(20):5479-5493. PubMed ID: 30293796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design.
    Darshit BS; Balaji B; Rani P; Ramanathan M
    J Mol Graph Model; 2014 Sep; 53():31-47. PubMed ID: 25064440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small molecules that inhibit GSK-3beta through virtual screening.
    Kang NS; Lee GN; Kim CH; Bae MA; Kim I; Cho YS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):533-7. PubMed ID: 19081248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
    Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.
    Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of inhibitors of glycogen synthase kinase-3β from traditional Chinese medicines using enzyme-immobilized magnetic beads combined with high-performance liquid chromatography.
    Li Y; Xu J; Chen Y; Mei Z; Xiao Y
    J Chromatogr A; 2015 Dec; 1425():8-16. PubMed ID: 26610618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays.
    Balboni B; Tripathi SK; Veronesi M; Russo D; Penna I; Giabbai B; Bandiera T; Storici P; Girotto S; Cavalli A
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays.
    Lin CH; Hsieh YS; Wu YR; Hsu CJ; Chen HC; Huang WH; Chang KH; Hsieh-Li HM; Su MT; Sun YC; Lee GC; Lee-Chen GJ
    Eur J Pharm Sci; 2016 Jun; 89():11-9. PubMed ID: 27094783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
    Francisco CS; Javarini CL; de S Barcelos I; Morais PAB; de Paula H; de S Borges W; Neto ÁC; Lacerda V
    Curr Top Med Chem; 2020; 20(2):153-160. PubMed ID: 31648640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.
    Hulcová D; Breiterová K; Siatka T; Klímová K; Davani L; Šafratová M; Hošťálková A; De Simone A; Andrisano V; Cahlíková L
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29561817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects.
    Cheng Z; Han T; Yao J; Wang K; Dong X; Yu F; Huang H; Han M; Liao Q; He S; Lyu W; Li Q
    Eur J Med Chem; 2024 Feb; 265():116065. PubMed ID: 38160617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mass spectrometry-based assay for GSK-3beta activity.
    Bowley E; Mulvihill E; Howard JC; Pak BJ; Gan BS; O'Gorman DB
    BMC Biochem; 2005 Dec; 6():29. PubMed ID: 16359552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry-based method to analyze the change in Tau phosphorylation in a hGSK-3beta and hTau over-expressing EcR-293 cell line.
    Kurko D; Boros A; Dezso P; Urbányi Z; Sárvári M; Nagy J; Szombathelyi Z; Szendrei GI
    Neurochem Int; 2006 Apr; 48(5):374-82. PubMed ID: 16420965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.